十三烷-6,8-二酮 | 32743-88-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 十三烷-6,8-二酮
• 英文名称: tridecane-6,8-dione
• 英文别名: Tridecan-6,8-dion；Dicaproylmethan；6,8-Tridecanedione
• CAS: 32743-88-7
• 化学式: C₁₃H₂₄O₂
• 分子量: 212.332
• InChiKey: ONLKWZYYIZMJRH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  15
• 可旋转键数：
  10
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.85
• 拓扑面积：
  34.1
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  十三烷-6,8-二酮 在 硫酸 作用下， 以 三氟乙酸 为溶剂， 反应 25.5h， 生成 dehydrolachnelluloic acid
  参考文献：
  名称：

  Ayer, William A.; Villar, J. Daniel Figueroa, Canadian Journal of Chemistry, 1985, vol. 63, p. 1161 - 1165

  摘要：

  DOI：
• 作为产物：
  描述：

  8-hydroxy-6-tridecanone 在 secondary-alcohol oxidase 氧气 作用下， 生成 十三烷-6,8-二酮
  参考文献：
  名称：

  Sakai, Kiyofumi; Hamada, Nobutake; Watanabe, Yasuto, Agricultural and Biological Chemistry, 1986, vol. 50, # 4, p. 989 - 996

  摘要：

  DOI：

文献信息

• Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase
  申请人：Nair Vasu

  公开号：US20060172973A1

  公开（公告）日：2006-08-03

  A new class of diketo acids constructed on nucleobase scaffolds, designed as inhibitors of HIV replication through inhibition of HIV integrase, is described. These compounds are useful in the prevention or treatment of infection by HIV and in the treatment of AIDS and ARC, either as the compounds, or as pharmaceutically acceptable salts, with pharmaceutically acceptable carriers, used alone or in combination with antivirals, immunomodulators, antibiotics, vaccines, and other therapeutic agents. Methods of treating AIDS and ARC and methods of treating or preventing infection by HIV are also described.

  一种新型的二酮酸类化合物，构建在核碱基支架上，设计为通过抑制HIV整合酶来抑制HIV复制，这些化合物可用于预防或治疗HIV感染，治疗艾滋病和ARC，可以作为化合物或药用盐的形式，与药用载体一起使用，单独或与抗病毒药物、免疫调节剂、抗生素、疫苗和其他治疗药物联合使用。还描述了治疗艾滋病和ARC的方法，以及治疗或预防HIV感染的方法。
• 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
  申请人：——

  公开号：US20030229079A1

  公开（公告）日：2003-12-11

  Certain 1-(aromatic- or heteroaromatic-substituted-3-(heteroaromatic substituted)-1,3-propanediones are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.

  某些1-(芳香基或杂芳基取代的3-(杂芳基取代)-1,3-丙二酮被描述为HIV整合酶的抑制剂和HIV复制的抑制剂。这些化合物在预防或治疗HIV感染以及治疗艾滋病方面是有用的，无论是作为化合物、药学上可接受的盐、药用组合成分，无论是否与其他抗病毒药物、免疫调节剂、抗生素或疫苗结合使用。还描述了治疗艾滋病的方法以及预防或治疗HIV感染的方法。
• Pyridinone diketo acids: inhibitors of HIV replication
  申请人：Nair Vasu

  公开号：US20080020010A1

  公开（公告）日：2008-01-24

  A new class of diketo acids constructed on pyridinone scaffolds, designed as inhibitors of HIV replication through inhibition of HIV integrase, is described. These compounds are useful in the prevention or treatment of infection by HIV and in the treatment of AIDS and ARC, either as the compounds, or as pharmaceutically acceptable salts, with pharmaceutically acceptable carriers, used alone or in combination with antivirals, immunomodulators, antibiotics, vaccines, and other therapeutic agents, especially other anti-HIV compounds (including other integrase-based anti-HIV agents). Methods of treating AIDS and ARC and methods of treating or preventing infection by HIV are also described.

  一种新型的二酮酸类化合物，构建在吡啶酮骨架上，设计为通过抑制HIV整合酶来抑制HIV复制的抑制剂。这些化合物可用于预防或治疗HIV感染，治疗艾滋病和ARC，可以作为化合物本身或作为药学上可接受的盐形式，与药学上可接受的载体一起使用，单独或与抗病毒药物、免疫调节剂、抗生素、疫苗和其他治疗剂一起使用，特别是其他抗HIV化合物（包括其他基于整合酶的抗HIV药物）。还描述了治疗艾滋病和ARC的方法，以及治疗或预防HIV感染的方法。
• Asymmetric Hydrogenation of 2,4-Disubstituted 1,5-Benzodiazepines Using Cationic Ruthenium Diamine Catalysts: An Unusual Achiral Counteranion Induced Reversal of Enantioselectivity
  作者：Zi-Yuan Ding、Fei Chen、Jie Qin、Yan-Mei He、Qing-Hua Fan

  DOI：10.1002/anie.201200309

  日期：2012.6.4

  highly enantioselective hydrogenation of 2,4‐disubstituted 1,5‐benzodiazepines using chiral cationic ruthenium diamine catalysts (R,R)‐1 has been developed (see scheme; BArF=tetrakis(3,5‐bistrifluoromethylphenyl)borate). Either enantiomer of 2,4‐diaryl‐2,3,4,5‐tetrahydro‐1H‐benzodiazepine derivatives could be obtained by using the same enantiomer of ligand but in the presence of a different achiral counteranion

  用另一种方法解决这个问题：已开发出使用手性阳离子钌二胺催化剂（R，R）-1对2,4-二取代的1,5-苯并二氮杂进行高度对映选择性加氢反应（参见方案; BArF = tetrakis（3,5-双三氟甲基苯基）硼酸酯）。2,4-二芳基-2,3,4,5-四氢-1 H-苯并二氮杂derivatives的对映异构体可以通过使用相同的配体对映异构体但存在不同的非手性抗衡阴离子来获得。
• Structure and Reactivity of Bis(iodozincio)methane in Tetrahydrothiophene
  作者：Seijiro Matsubara、Yuhei Yamamoto、Kiitiro Utimoto

  DOI：10.1055/s-1999-2877

  日期：1999.9

  Addition of tetrahydrothiophene (THT) to THF solution of bis(iodozincio)methane modified the stability and reactivity: EXAFS analysis indicated that THF stabilizes bis(iodozincio)methane in a monomeric structure; the species reacts with acyl chlorides to give 1,3-diketones.

  在双(碘锌基)甲烷的四氢呋喃溶液中加入四氢噻吩（THT）改进了其稳定性和反应活性：EXAFS分析表明，四氢呋喃使双(碘锌基)甲烷稳定在单体结构中；该物质与酰基氯反应生成1,3-二酮。